These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1651809)
1. Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism. Czerwinski M; McLemore TL; Philpot RM; Nhamburo PT; Korzekwa K; Gelboin HV; Gonzalez FJ Cancer Res; 1991 Sep; 51(17):4636-8. PubMed ID: 1651809 [TBL] [Abstract][Full Text] [Related]
2. Effect of carbon monoxide on the cytochrome P-450-mediated activation of 4-ipomeanol by the isolated perfused rabbit lung. Trela BA; Carlson GP; Turek J; Rebar A; Mathews JM J Toxicol Environ Health; 1989; 27(3):341-50. PubMed ID: 2754758 [TBL] [Abstract][Full Text] [Related]
3. Metabolic activation of 4-ipomeanol in human lung, primary pulmonary carcinomas, and established human pulmonary carcinoma cell lines. McLemore TL; Litterst CL; Coudert BP; Liu MC; Hubbard WC; Adelberg S; Czerwinski M; McMahon NA; Eggleston JC; Boyd MR J Natl Cancer Inst; 1990 Sep; 82(17):1420-6. PubMed ID: 2388294 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Smith TJ; Guo Z; Gonzalez FJ; Guengerich FP; Stoner GD; Yang CS Cancer Res; 1992 Apr; 52(7):1757-63. PubMed ID: 1312898 [TBL] [Abstract][Full Text] [Related]
5. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system. Slaughter SR; Statham CN; Philpot RM; Boyd MR J Pharmacol Exp Ther; 1983 Jan; 224(1):252-7. PubMed ID: 6848746 [TBL] [Abstract][Full Text] [Related]
6. CYP4B1 activates 4-ipomeanol in rat lung. Verschoyle RD; Philpot RM; Wolf CR; Dinsdale D Toxicol Appl Pharmacol; 1993 Dec; 123(2):193-8. PubMed ID: 8248926 [TBL] [Abstract][Full Text] [Related]
7. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol. Wolf CR; Statham CN; McMenamin MG; Bend JR; Boyd MR; Philpot RM Mol Pharmacol; 1982 Nov; 22(3):738-44. PubMed ID: 7155130 [TBL] [Abstract][Full Text] [Related]
8. In vitro studies on the metabolic activation of the pulmonary toxin, 4-ipomeanol, by rat lung and liver microsomes. Boyd MR; Burka LT; Wilson BJ; Sasame HA J Pharmacol Exp Ther; 1978 Dec; 207(3):677-86. PubMed ID: 32381 [TBL] [Abstract][Full Text] [Related]
9. Bioactivation of 4-ipomeanol by CYP4B1: adduct characterization and evidence for an enedial intermediate. Baer BR; Rettie AE; Henne KR Chem Res Toxicol; 2005 May; 18(5):855-64. PubMed ID: 15892579 [TBL] [Abstract][Full Text] [Related]
10. Regio- and stereo-selective metabolism of phenanthrene by twelve cDNA-expressed human, rodent, and rabbit cytochromes P-450. Shou M; Korzekwa KR; Krausz KW; Crespi CL; Gonzalez FJ; Gelboin HV Cancer Lett; 1994 Aug; 83(1-2):305-13. PubMed ID: 8062229 [TBL] [Abstract][Full Text] [Related]
11. Distribution and metabolism of the pulmonary alkylating agent and cytotoxin, 4-ipomeanol, in control and diethylmaleate-treated rats. Statham CN; Boyd MR Biochem Pharmacol; 1982 Apr; 31(8):1585-9. PubMed ID: 7092948 [TBL] [Abstract][Full Text] [Related]
12. 4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1. Smith PB; Tiano HF; Nesnow S; Boyd MR; Philpot RM; Langenbach R Biochem Pharmacol; 1995 Nov; 50(10):1567-75. PubMed ID: 7503758 [TBL] [Abstract][Full Text] [Related]
13. In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. Boyd MR; Burka LT J Pharmacol Exp Ther; 1978 Dec; 207(3):687-97. PubMed ID: 731424 [TBL] [Abstract][Full Text] [Related]
14. New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol. Rainov NG; Dobberstein KU; Sena-Esteves M; Herrlinger U; Kramm CM; Philpot RM; Hilton J; Chiocca EA; Breakefield XO Hum Gene Ther; 1998 Jun; 9(9):1261-73. PubMed ID: 9650611 [TBL] [Abstract][Full Text] [Related]
15. Metabolic activation and cytotoxicity of 4-ipomeanol in human non-small cell lung cancer lines. Falzon M; McMahon JB; Schuller HM; Boyd MR Cancer Res; 1986 Jul; 46(7):3484-9. PubMed ID: 3011249 [TBL] [Abstract][Full Text] [Related]
16. In vitro metabolic activation of the pulmonary toxin, 4-ipomeanol, in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lung. Devereux TR; Jones KG; Bend JR; Fouts JR; Statham CN; Boyd MR J Pharmacol Exp Ther; 1982 Jan; 220(1):223-7. PubMed ID: 7053419 [TBL] [Abstract][Full Text] [Related]
17. Metabolic basis for the pulmonary Clara cell as a target for pulmonary carcinogenesis. Boyd MR; Reznik-Schüller HM Toxicol Pathol; 1984; 12(1):56-61. PubMed ID: 6387866 [TBL] [Abstract][Full Text] [Related]
18. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428 [TBL] [Abstract][Full Text] [Related]
19. cDNA-directed expression of rat P450s IIA1 and IIA2. Catalytic activities toward steroids and xenobiotics and comparison with the enzymes purified from liver. Aoyama T; Korzekwa K; Matsunaga T; Nagata K; Gillette J; Gelboin HV; Gonzalez FJ Drug Metab Dispos; 1990; 18(3):378-82. PubMed ID: 1974203 [TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of a Cyp4b1 null mouse and the role of CYP4B1 in the activation and toxicity of Ipomeanol. Parkinson OT; Liggitt HD; Rettie AE; Kelly EJ Toxicol Sci; 2013 Aug; 134(2):243-50. PubMed ID: 23748241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]